Zynerba Pharmaceuticals, Inc. (ZYNE) - Stock Prices, Stock Peers & Analysis

Home
ZYNE

Company Name	Zynerba Pharmaceuticals, Inc.
Symbol	ZYNE
Currency	USD
Price	1.3
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	70,121,220
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.25 - 1.4
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Armando Anido MBA
Website	https://www.zynerba.com

An error occurred while fetching data.

About Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and